(Bloomberg) -- Bloomberg Intelligence analyst Eric Balchunas discusses the iShares Exponential Technologies ETF (ticker: XT), which has $604 million in total assets and was launched in March. Bloomberg’s Catherine Cowdery reports on exchange-traded funds.

(Bloomberg) -- Bloomberg Intelligence analyst Eric Balchunas discusses the SPDR DoubleLine Total Return Tactical ETF (ticker: TOTL) which has attracted $1.18 billion in assets since its launch in February. Bloomberg’s Catherine Cowdery reports on exchange-traded funds.

(Bloomberg) -- A group of high-frequency trading firms advised U.S. regulators on how to prevent a repeat of the Aug. 24 trading session that left ETFs’ prices out of sync with the value of their assets. Bloomberg Intelligence analyst Eric Balchunas has some advice for retail investors. Bloomberg’s Catherine Cowdery reports on exchange-traded funds.

(Bloomberg) -- Bloomberg Intelligence analyst Eric Balchunas says the number of new exchange-traded funds has already reached the annual record of 200. Bloomberg’s Catherine Cowdery reports on exchange-traded funds.

(Bloomberg) -- Jay Rhame, co-portfolio manager for the Reaves Utilities ETF, discusses the launch of the actively-managed fund and its investment goals. Bloomberg’s Catherine Cowdery reports on exchange-traded funds.

(Bloomberg) -- Bloomberg Intelligence analyst Eric Balchunas says investors appear unfazed by declines in the biggest currency-hedged ETFs, as their assets remain “sticky”. Bloomberg’s Catherine Cowdery reports on exchange-traded funds.

(Bloomberg) -- Bloomberg Intelligence analyst Eric Balchunas calls outflows from emerging-markets ETFs “brutal”. He says some emerging-markets ETFs have been able to attract new funds. Bloomberg’s Catherine Cowdery reports on exchange-traded funds.

(Bloomberg) -- Bloomberg Intelligence analyst Eric Balchunas discusses the launch today of Goldman Sachs’ first ETF. It’s the Goldman Sachs ActiveBeta U.S. Large Cap Equity ETF (ticker: GSLC). Bloomberg’s Catherine Cowdery reports on exchange-traded funds.

(Bloomberg) -- Bloomberg Intelligence analyst Eric Balchunas says biotechnology ETFs are leading all exchange-traded funds in 2015 returns. He discusses the ALPS Medical Breakthroughs ETF (ticker: SBIO) which is the top performing fund. Bloomberg’s Catherine Cowdery reports on exchange-traded funds.

(Bloomberg) -- Matthew Tucker, head of iShares fixed-income strategy at BlackRock, discusses three bond ETFs for a low interest rate environment (tickers: NEAR, CSJ and FLOT). Bloomberg’s Catherine Cowdery reports on exchange-traded funds.